RNA Vaccines & Therapeutics

RNA Vaccines & Therapeutics

Products & Services

Information

Developing RNA therapeutics and vaccines is a complex journey that involves numerous stages and logistical challenges, from discovery to clinical and commercial development. At Aldevron, we offer comprehensive support to drug developers, providing high-quality materials, custom manufacturing, and expert guidance. Our services span from DNA template and drug substance development to LNP encapsulation and fill/finish processes. By leveraging our expertise, innovative solutions, and cutting-edge tools, researchers can achieve precise and effective RNA therapy outcomes, paving the way for innovative treatments that can transform healthcare and improve lives. https://www.aldevron.com/modalities/rna-vaccine-therapeutics
Aldevron119Founded in 1998, Aldevron is a global leader in enabling the development of next-generation genomic medicines. As part of Danaher Corporation (NYSE: DHR) family of global science and technology companies, Aldevron empowers scientists and innovators worldwide to advance transformative therapies that are redefining the future of medicine. Aldevron’s expertise and integrated solutions have supported landmark achievements—including playing a key role in manufacturing the world’s first mRNA-based personalized CRISPR therapy. With facilities in Fargo, ND, Madison, WI and Waltham, MA, Aldevron is at the forefront of accelerating scientific discovery and expanding the possibilities of gene editing, gene therapy and other breakthrough modalities. By partnering with leading researchers and organizations, Aldevron is helping to turn the promise of genomic medicine into reality for patients around the globe.

Log in

See all the content and easy-to-use features by logging in or registering!